Steyerberg EW - Search Results

1

Active surveillance: a review of risk-based, dynamic monitoring.

Nieboer D, Tomer A, Rizopoulos D, Roobol MJ, Steyerberg EW. Nieboer D, et al. Among authors: steyerberg ew. Transl Androl Urol. 2018 Feb;7(1):106-115. doi: 10.21037/tau.2017.12.27. Transl Androl Urol. 2018. PMID: 29594025 Free PMC article. Review.

2

Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.

Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schröder FH. Steyerberg EW, et al. J Urol. 2007 Jan;177(1):107-12; discussion 112. doi: 10.1016/j.juro.2006.08.068. J Urol. 2007. PMID: 17162015

3

Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.

Roemeling S, Roobol MJ, Kattan MW, van der Kwast TH, Steyerberg EW, Schröder FH. Roemeling S, et al. Among authors: steyerberg ew. Cancer. 2007 Nov 15;110(10):2218-21. doi: 10.1002/cncr.23029. Cancer. 2007. PMID: 17893906 Free article. Clinical Trial.

4

Predictive models in diagnosing indolent cancer.

Bangma CH, Roobol MJ, Steyerberg EW. Bangma CH, et al. Among authors: steyerberg ew. Cancer. 2009 Jul 1;115(13 Suppl):3100-6. doi: 10.1002/cncr.24347. Cancer. 2009. PMID: 19544551 Free article. Review.

5

Disease insight and treatment perception of men on active surveillance for early prostate cancer.

van den Bergh RC, van Vugt HA, Korfage IJ, Steyerberg EW, Roobol MJ, Schröder FH, Essink-Bot ML. van den Bergh RC, et al. Among authors: steyerberg ew. BJU Int. 2010 Feb;105(3):322-8. doi: 10.1111/j.1464-410X.2009.08764.x. Epub 2009 Jul 7. BJU Int. 2010. PMID: 19594731

6

Anxiety and distress during active surveillance for early prostate cancer.

van den Bergh RC, Essink-Bot ML, Roobol MJ, Wolters T, Schröder FH, Bangma CH, Steyerberg EW. van den Bergh RC, et al. Among authors: steyerberg ew. Cancer. 2009 Sep 1;115(17):3868-78. doi: 10.1002/cncr.24446. Cancer. 2009. PMID: 19637245 Free article. Clinical Trial.

7

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

Roobol MJ, Steyerberg EW, Kranse R, Wolters T, van den Bergh RC, Bangma CH, Schröder FH. Roobol MJ, et al. Among authors: steyerberg ew. Eur Urol. 2010 Jan;57(1):79-85. doi: 10.1016/j.eururo.2009.08.025. Epub 2009 Sep 1. Eur Urol. 2010. PMID: 19733959

8

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC.

Wolters T, Roobol MJ, Steyerberg EW, van den Bergh RC, Bangma CH, Hugosson J, Ciatto S, Kwiatkowski M, Villers A, Luján M, Nelen V, Tammela TL, Schröder FH. Wolters T, et al. Among authors: steyerberg ew. Int J Cancer. 2010 May 15;126(10):2387-93. doi: 10.1002/ijc.24870. Int J Cancer. 2010. PMID: 19739124 Clinical Trial.

9

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH. van den Bergh RC, et al. Among authors: steyerberg ew. BJU Int. 2010 Apr;105(7):956-62. doi: 10.1111/j.1464-410X.2009.08887.x. Epub 2009 Oct 8. BJU Int. 2010. PMID: 19817747

10

Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.

van Vugt HA, Roobol MJ, Venderbos LD, Joosten-van Zwanenburg E, Essink-Bot ML, Steyerberg EW, Bangma CH, Korfage IJ. van Vugt HA, et al. Among authors: steyerberg ew. Eur J Cancer. 2010 Feb;46(3):669-77. doi: 10.1016/j.ejca.2009.11.022. Eur J Cancer. 2010. PMID: 20022239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,223 results

Search Page

Filters